Compare GNW & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNW | MMSI |
|---|---|---|
| Founded | 1871 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.1B |
| IPO Year | 2004 | 1996 |
| Metric | GNW | MMSI |
|---|---|---|
| Price | $9.69 | $89.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $10.50 | ★ $98.88 |
| AVG Volume (30 Days) | ★ 2.8M | 976.7K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | 0.24 | ★ 1.33 |
| Revenue | ★ $7,301,000,000.00 | $1,515,906,000.00 |
| Revenue This Year | N/A | $8.85 |
| Revenue Next Year | N/A | $5.88 |
| P/E Ratio | $80.92 | ★ $66.17 |
| Revenue Growth | 0.08 | ★ 11.75 |
| 52 Week Low | $7.84 | $59.74 |
| 52 Week High | $10.20 | $94.75 |
| Indicator | GNW | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 49.95 | 81.50 |
| Support Level | $8.01 | $79.55 |
| Resistance Level | $10.17 | $89.50 |
| Average True Range (ATR) | 0.21 | 2.98 |
| MACD | -0.06 | 1.03 |
| Stochastic Oscillator | 26.32 | 99.30 |
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has four main operating business segments: Enact, Closed Block segment, and Corporate and Other. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. The majority of the revenue is generated by the Enact segment. The company earns the maximum of its revenue in the United States.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.